Cyclosporin galenic forms

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S785000

Reexamination Certificate

active

07081445

ABSTRACT:
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.

REFERENCES:
patent: 3288824 (1966-11-01), Mahler et al.
patent: 4073920 (1978-02-01), Dowrick
patent: 4108985 (1978-08-01), Ruegger et al.
patent: 4210581 (1980-07-01), Ruegger et al.
patent: 4220641 (1980-09-01), Traber et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4390548 (1983-06-01), Yamato et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5338761 (1994-08-01), Nakajima et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5639724 (1997-06-01), Cavanak
patent: 5652212 (1997-07-01), Cavanak et al.
patent: 5759997 (1998-06-01), Cavanak
patent: 5916589 (1999-06-01), Hauer et al.
patent: 5977066 (1999-11-01), Cavanak
patent: 6262022 (2001-07-01), Hauer et al.
patent: 6306825 (2001-10-01), Cavanak
patent: 6468968 (2002-10-01), Cavanak et al.
patent: 895724 (1983-07-01), None
patent: 2461/78-6 (1983-06-01), None
patent: 8634/78-8 (1983-06-01), None
patent: 641356 (1984-02-01), None
patent: 0170623 (1986-02-01), None
patent: 2098865 (1982-12-01), None
patent: 2120935 (1983-12-01), None
patent: 2211848 (1989-07-01), None
Chemical Abstract 92:64765k (1980).
Cavanak et al., Prog. Allergy, vol. 38, pp. 65-72 j(1986).
Eckert et al., Chemical Abstracts, 89: 117875t (Jun. 8, 1978).
Chemical Abstracts, 89: 117874s (Jun. 8, 1978).
Takada et al., Int. J. of Pharmaceuticals vol. 44; 107-116 (1988).
Chemical Abstracts, 95: 225610K (1981).
Simpson et al., Chemical Abstracts 94: 327C (1981).
Takada et al., J. Pharmacobio-Dyn. vol. 11: 80-87 (1988).
Reymond et al., Pharmaceutical Research, vol. 5, No. 10, pp. 673-676 (1988).
Reymond, University of Basel (1986) Dissertation: In vitro in Vivo Model for the Absorption of Cyclosporin A.
Cavanak, Chemical Abstracts, 92: 64765k (1980).
Derwent Abstracts, 84-069426/12 (Feb. 19, 1984). (Abstract of JA 61/280,435, Published Dec. 11, 1986).
Miglyol-Neutral Oil, Dynamit Nobel Chemicals (1975).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclosporin galenic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclosporin galenic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin galenic forms will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3571024

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.